0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharma & Cosmetics Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-6Q10541
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharma Cosmetics Market Insights Forecast to 2028
BUY CHAPTERS

Global Biopharma & Cosmetics Market Research Report 2025

Code: QYRE-Auto-6Q10541
Report
June 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharma & Cosmetics Market Size

The global market for Biopharma & Cosmetics was valued at US$ 1877600 million in the year 2024 and is projected to reach a revised size of US$ 2577950 million by 2031, growing at a CAGR of 4.7% during the forecast period.

Biopharma & Cosmetics Market

Biopharma & Cosmetics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharma & Cosmetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma & Cosmetics.
The Biopharma & Cosmetics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharma & Cosmetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharma & Cosmetics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biopharma & Cosmetics Market Report

Report Metric Details
Report Name Biopharma & Cosmetics Market
Accounted market size in year US$ 1877600 million
Forecasted market size in 2031 US$ 2577950 million
CAGR 4.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Pharmaceuticals, OTC
  • Cosmetics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Roche, Novartis, Pfizer, Sanofi, Eli Lilly, GSK, Bayer, Merck & Co, L' OREAL, Unilever, Procter & Gamble, Estee Lauder, Kao, Shiseido, Beiersdorf, Henkel, Shanghai Jahwa
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biopharma & Cosmetics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biopharma & Cosmetics Market growing?

Ans: The Biopharma & Cosmetics Market witnessing a CAGR of 4.7% during the forecast period 2025-2031.

What is the Biopharma & Cosmetics Market size in 2031?

Ans: The Biopharma & Cosmetics Market size in 2031 will be US$ 2577950 million.

Who are the main players in the Biopharma & Cosmetics Market report?

Ans: The main players in the Biopharma & Cosmetics Market are Johnson & Johnson, Roche, Novartis, Pfizer, Sanofi, Eli Lilly, GSK, Bayer, Merck & Co, L' OREAL, Unilever, Procter & Gamble, Estee Lauder, Kao, Shiseido, Beiersdorf, Henkel, Shanghai Jahwa

What are the Application segmentation covered in the Biopharma & Cosmetics Market report?

Ans: The Applications covered in the Biopharma & Cosmetics Market report are Pharmaceuticals, OTC, Cosmetics

What are the Type segmentation covered in the Biopharma & Cosmetics Market report?

Ans: The Types covered in the Biopharma & Cosmetics Market report are Ointments, Creams, Gel, Others

Recommended Reports

Biopharmaceutical Markets

Pharmaceutical Drugs

Cosmetics & Dermatology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharma & Cosmetics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ointments
1.2.3 Creams
1.2.4 Gel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biopharma & Cosmetics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals, OTC
1.3.3 Cosmetics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharma & Cosmetics Market Perspective (2020-2031)
2.2 Global Biopharma & Cosmetics Growth Trends by Region
2.2.1 Global Biopharma & Cosmetics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharma & Cosmetics Historic Market Size by Region (2020-2025)
2.2.3 Biopharma & Cosmetics Forecasted Market Size by Region (2026-2031)
2.3 Biopharma & Cosmetics Market Dynamics
2.3.1 Biopharma & Cosmetics Industry Trends
2.3.2 Biopharma & Cosmetics Market Drivers
2.3.3 Biopharma & Cosmetics Market Challenges
2.3.4 Biopharma & Cosmetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharma & Cosmetics Players by Revenue
3.1.1 Global Top Biopharma & Cosmetics Players by Revenue (2020-2025)
3.1.2 Global Biopharma & Cosmetics Revenue Market Share by Players (2020-2025)
3.2 Global Biopharma & Cosmetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharma & Cosmetics Revenue
3.4 Global Biopharma & Cosmetics Market Concentration Ratio
3.4.1 Global Biopharma & Cosmetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharma & Cosmetics Revenue in 2024
3.5 Global Key Players of Biopharma & Cosmetics Head office and Area Served
3.6 Global Key Players of Biopharma & Cosmetics, Product and Application
3.7 Global Key Players of Biopharma & Cosmetics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharma & Cosmetics Breakdown Data by Type
4.1 Global Biopharma & Cosmetics Historic Market Size by Type (2020-2025)
4.2 Global Biopharma & Cosmetics Forecasted Market Size by Type (2026-2031)
5 Biopharma & Cosmetics Breakdown Data by Application
5.1 Global Biopharma & Cosmetics Historic Market Size by Application (2020-2025)
5.2 Global Biopharma & Cosmetics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharma & Cosmetics Market Size (2020-2031)
6.2 North America Biopharma & Cosmetics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharma & Cosmetics Market Size by Country (2020-2025)
6.4 North America Biopharma & Cosmetics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharma & Cosmetics Market Size (2020-2031)
7.2 Europe Biopharma & Cosmetics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharma & Cosmetics Market Size by Country (2020-2025)
7.4 Europe Biopharma & Cosmetics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharma & Cosmetics Market Size (2020-2031)
8.2 Asia-Pacific Biopharma & Cosmetics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharma & Cosmetics Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharma & Cosmetics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharma & Cosmetics Market Size (2020-2031)
9.2 Latin America Biopharma & Cosmetics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharma & Cosmetics Market Size by Country (2020-2025)
9.4 Latin America Biopharma & Cosmetics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharma & Cosmetics Market Size (2020-2031)
10.2 Middle East & Africa Biopharma & Cosmetics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharma & Cosmetics Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharma & Cosmetics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Biopharma & Cosmetics Introduction
11.1.4 Johnson & Johnson Revenue in Biopharma & Cosmetics Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Biopharma & Cosmetics Introduction
11.2.4 Roche Revenue in Biopharma & Cosmetics Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Biopharma & Cosmetics Introduction
11.3.4 Novartis Revenue in Biopharma & Cosmetics Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Biopharma & Cosmetics Introduction
11.4.4 Pfizer Revenue in Biopharma & Cosmetics Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Biopharma & Cosmetics Introduction
11.5.4 Sanofi Revenue in Biopharma & Cosmetics Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Biopharma & Cosmetics Introduction
11.6.4 Eli Lilly Revenue in Biopharma & Cosmetics Business (2020-2025)
11.6.5 Eli Lilly Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Biopharma & Cosmetics Introduction
11.7.4 GSK Revenue in Biopharma & Cosmetics Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Biopharma & Cosmetics Introduction
11.8.4 Bayer Revenue in Biopharma & Cosmetics Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Merck & Co
11.9.1 Merck & Co Company Details
11.9.2 Merck & Co Business Overview
11.9.3 Merck & Co Biopharma & Cosmetics Introduction
11.9.4 Merck & Co Revenue in Biopharma & Cosmetics Business (2020-2025)
11.9.5 Merck & Co Recent Development
11.10 L' OREAL
11.10.1 L' OREAL Company Details
11.10.2 L' OREAL Business Overview
11.10.3 L' OREAL Biopharma & Cosmetics Introduction
11.10.4 L' OREAL Revenue in Biopharma & Cosmetics Business (2020-2025)
11.10.5 L' OREAL Recent Development
11.11 Unilever
11.11.1 Unilever Company Details
11.11.2 Unilever Business Overview
11.11.3 Unilever Biopharma & Cosmetics Introduction
11.11.4 Unilever Revenue in Biopharma & Cosmetics Business (2020-2025)
11.11.5 Unilever Recent Development
11.12 Procter & Gamble
11.12.1 Procter & Gamble Company Details
11.12.2 Procter & Gamble Business Overview
11.12.3 Procter & Gamble Biopharma & Cosmetics Introduction
11.12.4 Procter & Gamble Revenue in Biopharma & Cosmetics Business (2020-2025)
11.12.5 Procter & Gamble Recent Development
11.13 Estee Lauder
11.13.1 Estee Lauder Company Details
11.13.2 Estee Lauder Business Overview
11.13.3 Estee Lauder Biopharma & Cosmetics Introduction
11.13.4 Estee Lauder Revenue in Biopharma & Cosmetics Business (2020-2025)
11.13.5 Estee Lauder Recent Development
11.14 Kao
11.14.1 Kao Company Details
11.14.2 Kao Business Overview
11.14.3 Kao Biopharma & Cosmetics Introduction
11.14.4 Kao Revenue in Biopharma & Cosmetics Business (2020-2025)
11.14.5 Kao Recent Development
11.15 Shiseido
11.15.1 Shiseido Company Details
11.15.2 Shiseido Business Overview
11.15.3 Shiseido Biopharma & Cosmetics Introduction
11.15.4 Shiseido Revenue in Biopharma & Cosmetics Business (2020-2025)
11.15.5 Shiseido Recent Development
11.16 Beiersdorf
11.16.1 Beiersdorf Company Details
11.16.2 Beiersdorf Business Overview
11.16.3 Beiersdorf Biopharma & Cosmetics Introduction
11.16.4 Beiersdorf Revenue in Biopharma & Cosmetics Business (2020-2025)
11.16.5 Beiersdorf Recent Development
11.17 Henkel
11.17.1 Henkel Company Details
11.17.2 Henkel Business Overview
11.17.3 Henkel Biopharma & Cosmetics Introduction
11.17.4 Henkel Revenue in Biopharma & Cosmetics Business (2020-2025)
11.17.5 Henkel Recent Development
11.18 Shanghai Jahwa
11.18.1 Shanghai Jahwa Company Details
11.18.2 Shanghai Jahwa Business Overview
11.18.3 Shanghai Jahwa Biopharma & Cosmetics Introduction
11.18.4 Shanghai Jahwa Revenue in Biopharma & Cosmetics Business (2020-2025)
11.18.5 Shanghai Jahwa Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biopharma & Cosmetics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ointments
 Table 3. Key Players of Creams
 Table 4. Key Players of Gel
 Table 5. Key Players of Others
 Table 6. Global Biopharma & Cosmetics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Biopharma & Cosmetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biopharma & Cosmetics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Biopharma & Cosmetics Market Share by Region (2020-2025)
 Table 10. Global Biopharma & Cosmetics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Biopharma & Cosmetics Market Share by Region (2026-2031)
 Table 12. Biopharma & Cosmetics Market Trends
 Table 13. Biopharma & Cosmetics Market Drivers
 Table 14. Biopharma & Cosmetics Market Challenges
 Table 15. Biopharma & Cosmetics Market Restraints
 Table 16. Global Biopharma & Cosmetics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Biopharma & Cosmetics Market Share by Players (2020-2025)
 Table 18. Global Top Biopharma & Cosmetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma & Cosmetics as of 2024)
 Table 19. Ranking of Global Top Biopharma & Cosmetics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Biopharma & Cosmetics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Biopharma & Cosmetics, Headquarters and Area Served
 Table 22. Global Key Players of Biopharma & Cosmetics, Product and Application
 Table 23. Global Key Players of Biopharma & Cosmetics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Biopharma & Cosmetics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Biopharma & Cosmetics Revenue Market Share by Type (2020-2025)
 Table 27. Global Biopharma & Cosmetics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Biopharma & Cosmetics Revenue Market Share by Type (2026-2031)
 Table 29. Global Biopharma & Cosmetics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Biopharma & Cosmetics Revenue Market Share by Application (2020-2025)
 Table 31. Global Biopharma & Cosmetics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Biopharma & Cosmetics Revenue Market Share by Application (2026-2031)
 Table 33. North America Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Biopharma & Cosmetics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Biopharma & Cosmetics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Biopharma & Cosmetics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Johnson & Johnson Company Details
 Table 49. Johnson & Johnson Business Overview
 Table 50. Johnson & Johnson Biopharma & Cosmetics Product
 Table 51. Johnson & Johnson Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 52. Johnson & Johnson Recent Development
 Table 53. Roche Company Details
 Table 54. Roche Business Overview
 Table 55. Roche Biopharma & Cosmetics Product
 Table 56. Roche Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 57. Roche Recent Development
 Table 58. Novartis Company Details
 Table 59. Novartis Business Overview
 Table 60. Novartis Biopharma & Cosmetics Product
 Table 61. Novartis Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 62. Novartis Recent Development
 Table 63. Pfizer Company Details
 Table 64. Pfizer Business Overview
 Table 65. Pfizer Biopharma & Cosmetics Product
 Table 66. Pfizer Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 67. Pfizer Recent Development
 Table 68. Sanofi Company Details
 Table 69. Sanofi Business Overview
 Table 70. Sanofi Biopharma & Cosmetics Product
 Table 71. Sanofi Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 72. Sanofi Recent Development
 Table 73. Eli Lilly Company Details
 Table 74. Eli Lilly Business Overview
 Table 75. Eli Lilly Biopharma & Cosmetics Product
 Table 76. Eli Lilly Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 77. Eli Lilly Recent Development
 Table 78. GSK Company Details
 Table 79. GSK Business Overview
 Table 80. GSK Biopharma & Cosmetics Product
 Table 81. GSK Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 82. GSK Recent Development
 Table 83. Bayer Company Details
 Table 84. Bayer Business Overview
 Table 85. Bayer Biopharma & Cosmetics Product
 Table 86. Bayer Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 87. Bayer Recent Development
 Table 88. Merck & Co Company Details
 Table 89. Merck & Co Business Overview
 Table 90. Merck & Co Biopharma & Cosmetics Product
 Table 91. Merck & Co Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 92. Merck & Co Recent Development
 Table 93. L' OREAL Company Details
 Table 94. L' OREAL Business Overview
 Table 95. L' OREAL Biopharma & Cosmetics Product
 Table 96. L' OREAL Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 97. L' OREAL Recent Development
 Table 98. Unilever Company Details
 Table 99. Unilever Business Overview
 Table 100. Unilever Biopharma & Cosmetics Product
 Table 101. Unilever Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 102. Unilever Recent Development
 Table 103. Procter & Gamble Company Details
 Table 104. Procter & Gamble Business Overview
 Table 105. Procter & Gamble Biopharma & Cosmetics Product
 Table 106. Procter & Gamble Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 107. Procter & Gamble Recent Development
 Table 108. Estee Lauder Company Details
 Table 109. Estee Lauder Business Overview
 Table 110. Estee Lauder Biopharma & Cosmetics Product
 Table 111. Estee Lauder Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 112. Estee Lauder Recent Development
 Table 113. Kao Company Details
 Table 114. Kao Business Overview
 Table 115. Kao Biopharma & Cosmetics Product
 Table 116. Kao Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 117. Kao Recent Development
 Table 118. Shiseido Company Details
 Table 119. Shiseido Business Overview
 Table 120. Shiseido Biopharma & Cosmetics Product
 Table 121. Shiseido Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 122. Shiseido Recent Development
 Table 123. Beiersdorf Company Details
 Table 124. Beiersdorf Business Overview
 Table 125. Beiersdorf Biopharma & Cosmetics Product
 Table 126. Beiersdorf Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 127. Beiersdorf Recent Development
 Table 128. Henkel Company Details
 Table 129. Henkel Business Overview
 Table 130. Henkel Biopharma & Cosmetics Product
 Table 131. Henkel Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 132. Henkel Recent Development
 Table 133. Shanghai Jahwa Company Details
 Table 134. Shanghai Jahwa Business Overview
 Table 135. Shanghai Jahwa Biopharma & Cosmetics Product
 Table 136. Shanghai Jahwa Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
 Table 137. Shanghai Jahwa Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Biopharma & Cosmetics Picture
 Figure 2. Global Biopharma & Cosmetics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biopharma & Cosmetics Market Share by Type: 2024 VS 2031
 Figure 4. Ointments Features
 Figure 5. Creams Features
 Figure 6. Gel Features
 Figure 7. Others Features
 Figure 8. Global Biopharma & Cosmetics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Biopharma & Cosmetics Market Share by Application: 2024 VS 2031
 Figure 10. Pharmaceuticals, OTC Case Studies
 Figure 11. Cosmetics Case Studies
 Figure 12. Biopharma & Cosmetics Report Years Considered
 Figure 13. Global Biopharma & Cosmetics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Biopharma & Cosmetics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Biopharma & Cosmetics Market Share by Region: 2024 VS 2031
 Figure 16. Global Biopharma & Cosmetics Market Share by Players in 2024
 Figure 17. Global Top Biopharma & Cosmetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma & Cosmetics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Biopharma & Cosmetics Revenue in 2024
 Figure 19. North America Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Biopharma & Cosmetics Market Share by Country (2020-2031)
 Figure 21. United States Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Biopharma & Cosmetics Market Share by Country (2020-2031)
 Figure 25. Germany Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Biopharma & Cosmetics Market Share by Region (2020-2031)
 Figure 33. China Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Biopharma & Cosmetics Market Share by Country (2020-2031)
 Figure 41. Mexico Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Biopharma & Cosmetics Market Share by Country (2020-2031)
 Figure 45. Turkey Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Johnson & Johnson Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 49. Roche Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 52. Sanofi Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 53. Eli Lilly Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 54. GSK Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 55. Bayer Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 56. Merck & Co Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 57. L' OREAL Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 58. Unilever Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 59. Procter & Gamble Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 60. Estee Lauder Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 61. Kao Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 62. Shiseido Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 63. Beiersdorf Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 64. Henkel Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 65. Shanghai Jahwa Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart